Blueprints of signaling interactions between pattern recognition receptors: Implications for the design of vaccine adjuvants

Clinical and Vaccine Immunology

Volumn 20, Issue 3, 2013, Pages 427-432

  Timmermans, Kim ^a   Plantinga, Theo S ^a   Kox, Matthijs ^a   Vaneker, Michiel ^a   Scheffer, Gert Jan ^a   Adema, Gosse J ^b   Joosten, Leo A B ^a   Neteaa, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; DECTIN 1; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LECTIN RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG DESIGN; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INCUBATION TIME; INNATE IMMUNITY; MOLECULAR INTERACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPERNATANT;

ADJUVANTS, IMMUNOLOGIC; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN EXPERIMENTATION; HUMANS; LEUKOCYTES, MONONUCLEAR; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; VACCINES;

EID: 84875027497     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00703-12     Document Type: Article

References (29)

1. Bourhis LL, Werts C. 2007. Role of Nods in bacterial infection. Microbes Infect. 9:629-636.
2. Shaw MH, Reimer T, Kim YG, Nunez G. 2008. NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr. Opin. Immunol. 20:377-382.
3. Testro AG, Visvanathan K. 2009. Toll-like receptors and their role in gastrointestinal disease. J. Gastroenterol. Hepatol. 24:943-954.
4. Bagchi A, Herrup EA, Warren HS, Trigilio J, Shin HS, Valentine C, Hellman J. 2007. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J. Immunol. 178:1164-1171.
5. Fitzgerald KA, Chen ZJ. 2006. Sorting out Toll signals. Cell 125:834-836.
6. Lee MS, Kim YJ. 2007. Signaling pathways downstream of patternrecognition receptors and their cross talk. Annu. Rev. Biochem. 76:447-480.
7. Kumar H, Kawai T, Akira S. 2009. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388:621-625.
8. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U. S. A. 95:588-593.
9. van Vliet SJ, den Dunnen J, Gringhuis SI, Geijtenbeek TB, and van Kooyk Y. 2007. Innate signaling and regulation of Dendritic cell immunity. Curr. Opin. Immunol. 19:435-440.
10. Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131-137.
11. Jeong E, Lee JY. 2011. Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med. J. 52:379-392.
12. den Dunnen J, Gringhuis SI, Geijtenbeek TB. 2010. Dusting the sugar fingerprint: C-type lectin signaling in adaptive immunity. Immunol. Lett. 128:12-16.
13. Shaw MH, Kamada N, Warner N, Kim YG, Nunez G. 2011. The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation. Trends Immunol. 32:73-79.
14. Baek YS, Haas S, Hackstein H, Bein G, Hernandez-Santana M, Lehrach H, Sauer S, Seitz H. 2009. Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells. BMC Immunol. 10:18. doi:10.1186/1471-2172-10-18.
15. Kufer TA, Sansonetti PJ. 2007. Sensing of bacteria: NOD a lonely job. Curr. Opin. Microbiol. 10:62-69.
16. Ferwerda G, Meyer-Wentrup F, Kullberg BJ, Netea MG, Adema GJ. 2008. Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell. Microbiol. 10:2058-2066.
17. Watanabe T, Kitani A, Murray PJ, Strober W. 2004. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5:800-808.
18. Zhu Q, Egelston C, Vivekanandhan A, Uematsu S, Akira S, Klinman DM, Belyakov IM, Berzofsky JA. 2008. Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines. Proc. Natl. Acad. Sci. U. S. A. 105:16260-16265.
19. Kox M, van Velzen JF, Pompe JC, Hoedemaekers CW, van der Hoeven JG, Pickkers P. 2009. GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation. Biochem. Pharmacol. 78:863-872.
20. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165:618-622.
21. Chapekar MS, Zaremba TG, Kuester RK, Hitchins VM. 1996. Synergistic induction of tumor necrosis factor alpha by bacterial lipopolysaccharide and lipoteichoic acid in combination with polytetrafluoroethylene particles in a murine macrophage cell line RAW 264.7. J. Biomed. Mater. Res. 31:251-256.
22. Jung YO, Cho ML, Lee SY, Oh HJ, Park JS, Park MK, Park MJ, Ju JH, Kim SI, Park SH, Kim HY, Min JK. 2009. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice. Immunol. Lett. 123:138-143.
23. Sato S, Nomura F, Kawai T, Takeuchi O, Muhlradt PF, Takeda K, Akira S. 2000. Synergy and cross-tolerance between toll-like receptor (TLR) 2-and TLR4-mediated signaling pathways. J. Immunol. 165:7096-7101.
24. Shinohara M, Hirata K, Yamashita T, Takaya T, Sasaki N, Shiraki R, Ueyama T, Emoto N, Inoue N, Yokoyama M, Kawashima S. 2007. Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation: synergism of TLR2 and TLR4. Arterioscler. Thromb. Vasc. Biol. 27:2384-2391. 25. Xu WY, Wang L, Wang HM, Wang YQ, Liang YF, Zhao TT, Wu YZ. 2007. TLR2 and TLR4 agonists synergistically up-regulate SR-A in RAW264.7 through p38. Mol. Immunol. 44:2315-2323.
25. Henckaerts L, Nielsen KR, Steffensen R, Van Steen K, Mathieu C, Giulietti A, Wouters PJ, Milants I, Vanhorebeek I, Langouche L, Vermeire S, Rutgeerts P, Thiel S, Wilmer A, Hansen TK, and Van den Berghe G. 2009. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit. Care Med. 37:192-193.
26. Kullberg BJ, Ferwerda G, de Jong DJ, Drenth JP, Joosten LA, Van der Meer JW, Netea MG. 2008. Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli. Immunology 123:600-605.
27. Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J. 2010. Biology of interleukin-10. Cytokine Growth Factor Rev. 21:331-344.
28. Apostolopoulos V, McKenzie IF. 2001. Role of the mannose receptor in the immune response. Curr. Mol. Med. 1:469-474.
29. Crespo-Lessmann A, Juarez-Rubio C, Plaza-Moral V. 2010. Role of toll-like receptors in respiratory diseases. Arch. Bronconeumol. 46:135-142. (In Spanish.)